Lunit

Lunit Intangible Assets

The Intangible Assets of Lunit (328130.KQ) as of Oct 17, 2026 is 424.20 M KRW. In the previous year, Intangible Assets was 465.04 M KRW — a change of -8.78% (lower).

Intangible Assets

424.20 MKRW

YoY

-8.78%

Last updated:

Intangible Assets of Lunit is 2024 424.20 M KRW. Intangible Assets of Lunit was 2023 465.04 M KRW. It decreases by -8.78% lower compared to the previous year.

The Lunit Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2019
66.76 M KRW
Jan 1, 2020
242.96 M KRW
Jan 1, 2021
447.58 M KRW
Jan 1, 2022
284.02 M KRW
Jan 1, 2023
465.04 M KRW
Jan 1, 2024
424.20 M KRW
The Lunit Intangible Assets history
YEARIntangible AssetsYoY
424.20 MKRW-8.78%
465.04 MKRW+63.73%
284.02 MKRW-36.54%
447.58 MKRW+84.22%
242.96 MKRW+263.93%
66.76 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lunit Stock analysis

What does Lunit do? Lunit Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company has 293 employees and went public on July 21, 2022, with its ticker listed as 328130.KQ and ISIN KR7328130000. Lunit provides software solutions for medical diagnostic imaging services, focusing on the development and supply of AI-powered medical software. Its offerings include cancer diagnostic aid solutions, cancer early detection solutions, and cancer risk prediction solutions. The company's technology leverages artificial intelligence to enhance diagnostic capabilities in healthcare settings. Lunit's website is www.lunit.io, where further information about its services and solutions can be accessed. The company operates in the Health Care industry, specifically targeting medical imaging and AI-driven diagnostic tools. As of the latest available data, Lunit is engaged in the development and commercialization of AI-based medical software, aiming to improve the accuracy and efficiency of cancer-related diagnostics. The firm's IPO date marks its transition to a publicly traded company, reflecting its growth and market position in the healthcare technology space. Lunit's focus on AI applications in medical imaging positions it as a key player in the digital health sector, particularly within the Korean market and beyond. The company's solutions are designed to support healthcare professionals in making more informed diagnostic decisions, potentially reducing the time and resources required for cancer detection and treatment planning. Lunit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lunit stock

Intangible Assets of Lunit is 424.20 M KRW in 2024.

Intangible Assets of Lunit changed from 465.04 M KRW to 424.20 M KRW, representing a -8.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Lunit since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Lunit historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Lunit

All Key Metrics — Lunit